Collaboration Is Needed on COVID Vaccine Dosing, Specialty Drugs
Many people taking specialty medications, such as people with cancer, are immunocompromised, and specialty drugs themselves can cause drug-induced immunosuppression. As COVID-19 vaccines roll out, it may be unclear how those products could impact people taking specialty therapies. At least one medical society, however, has released a guidance summary, and industry experts say that all stakeholders, including specialty pharmacies, have a role to play in making sure people getting vaccinated do so in the most effective, safest way possible.
In February, the American College of Rheumatology (ACR) released its COVID-19 Vaccine Clinical Guidance Summary, which provides recommendations on vaccinating people with musculoskeletal, inflammatory and autoimmune diseases. A panel of nine rheumatologists, two infectious disease specialists and two public health experts developed the guidance through multiple meetings in December and January. The guidance was updated on March 4.
Related Posts

Study Finds Fertility Program Prevents Medication Waste, Loss, Missed Doses
READ MORE
AbbVie Files Lawsuit Against Alternate Funding Company Payer Matrix Alleging ‘Fraudulent and Deceptive Scheme’
READ MORE